Diametric Capital’s Envoy Medical Warrant COCHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.7K Sell
236,254
-22,074
-9% -$1.18K ﹤0.01% 471
2025
Q4
$10K Hold
258,328
﹤0.01% 363
2025
Q3
$9.71K Hold
258,328
﹤0.01% 369
2025
Q2
$9.12K Hold
258,328
﹤0.01% 310
2025
Q1
$8.52K Hold
258,328
0.01% 204
2024
Q4
$12.1K Hold
258,328
0.01% 298
2024
Q3
$20.5K Hold
258,328
0.01% 354
2024
Q2
$12.9K Hold
258,328
0.01% 351
2024
Q1
$27.5K Sell
258,328
-275,792
-52% -$18.5K 0.02% 312
2023
Q4
$10.7K Buy
+534,120
New +$14.4K 0.01% 255
2023
Q3
Sell
-534,120
Closed -$24.9K 356
2023
Q2
$24.9K Buy
534,120
+39,120
+8% +$1.97K 0.01% 319
2023
Q1
$17.4K Hold
495,000
0.01% 326
2022
Q4
$18.8K Buy
+495,000
New +$23.5K 0.01% 281

Other funds holding COCHW

Diametric Capital's COCHW Position: Q1 2026 in Review

Diametric Capital reduced its Envoy Medical Warrant (COCHW) stake by 8.5% in Q1 2026, selling an estimated $1.18K and leaving 236,254 shares worth $15.7K. The position accounts for ﹤0.01% of the portfolio, ranked #471.

Diametric Capital first reported a position in COCHW in Q4 2022 and has held it in 13 quarters since. The position peaked at $27.5K in Q1 2024. 34 funds tracked by Wall St. Rank hold COCHW as of Q1 2026.

  • Diametric Capital held 236,254 shares of Envoy Medical Warrant worth $15.7K as of Q1 2026.
  • Diametric Capital sold 22,074 Envoy Medical Warrant shares in Q1 2026, an estimated $1.18K.
  • Envoy Medical Warrant made up ﹤0.01% of Diametric Capital's portfolio in Q1 2026, its #471 holding.
  • Diametric Capital first reported a position in Envoy Medical Warrant in Q4 2022 and has held it in 13 quarters since.
  • Diametric Capital's Envoy Medical Warrant position peaked at $27.5K in Q1 2024.
  • 34 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q1 2026.

Based on Diametric Capital's 13F filing for Q1 2026, filed 15 May 2026.